Effects of a Specific Cysteinyl Leukotriene Antagonist, Pranlukast, on Antigen-Induced Cysteinyl Leukotriene-Mediated Rhinitis in Guinea Pigs
Open Access
- 1 January 1997
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 75 (4) , 347-353
- https://doi.org/10.1254/jjp.75.347
Abstract
To examine the effects of a specific cysteinyl leukotriene (cysLT) antagonist, pranlukast, on allergic rhinitis, antigen-induced rhinitis in guinea pigs was modified by pretreatment with an cyclooxygenase inhibitor (indomethacin) followed by an H1-blocker (pyrilamine). Intranasal ovalbumin (OVA) administration in actively sensitized guinea pigs resulted in concentration-dependent increases in nasal permeability and nasal airway resistance (NAR). Although pyrilamine (1 mg/kg, i.v.) abolished these antigen-induced changes, pretreatment with indomethacin (5 mg/kg, i.v.) followed by pyrilamine enhanced these responses to a degree similar to that observed with OVA challenge alone. Analyses of nasal perfusate in indomethacin/pyrilamine-pretreated animals showed that cysLTs increased by 270.8%, whereas thromboxane B2 decreased by 88.3% as compared with those on challenged with OVA alone. Oral administration of pranlukast (1-10 mg/kg) dose-dependently prevented increases in nasal permeability and NAR of indomethacin/pyrilamine-pretreated animals. However, an anti-allergic agent, azelastine, did not affect these responses. These results indicate that pranlukast suppresses antigen-induced cysLT-mediated responses of allergic rhinitis in actively sensitized guinea pigs. A cysLT antagonist, pranlukast, may thus prevent cysLT-mediated symptoms of allergic rhinitis.Keywords
This publication has 18 references indexed in Scilit:
- The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis.American Journal of Respiratory and Critical Care Medicine, 1995
- Effect of a peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig models of asthmaEuropean Journal of Pharmacology, 1993
- Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthmaRespiratory Medicine, 1993
- Mediators of allergic rhinitisJournal of Allergy and Clinical Immunology, 1992
- In Vivo Pharmacologic Profile of ONO-1078: A Potent, Selective and Orally Active Peptide Leukotriene (LT) Antagonist.The Japanese Journal of Pharmacology, 1992
- Leukotrienes in Asthma and Allergic RhinitisNew England Journal of Medicine, 1990
- The effect of a leukotriene antagonist on the early response to antigenOtolaryngology -- Head and Neck Surgery, 1990
- The effect of leukotriene antagonists, lipoxygenase inhibitors and selected standards on leukotriene-mediated allergic bronchospasm in guinea pigsInflammation Research, 1989
- Induction of nasal late-phase reactions by insufflation of ragweed-pollen extractJournal of Allergy and Clinical Immunology, 1984
- An in vivo model for measuring antigen‐induced SRS‐A‐mediated bronchoconstriction and plasma S RS‐ A levels in the guinea‐pigBritish Journal of Pharmacology, 1983